Skip to content
The Policy VaultThe Policy Vault

NoxafilMedica

Esophageal Candidiasis in a Patient with Human Immunodeficiency Virus (HIV) Infection – Chronic Suppressive Treatment

Initial criteria

  • Approve for 6 months.

Approval duration

6 months